Albion Financial Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,000
Closed -$25.9K 494
2023
Q1
$25.9K Sell
1,000
-25
-2% -$669 ﹤0.01% 242
2022
Q4
$24.2K Buy
1,025
+25
+3% +$674 ﹤0.01% 247
2022
Q3
$25K Hold
1,000
﹤0.01% 244
2022
Q2
$33K Sell
1,000
-9
-0.9% -$382 ﹤0.01% 236
2022
Q1
$73K Buy
1,009
+9
+0.9% +$648 0.01% 243
2021
Q4
$92K Hold
1,000
0.01% 249
2021
Q3
$127K Hold
1,000
0.01% 200
2021
Q2
$166K Buy
+1,000
New +$162K 0.01% 194
2020
Q4
$200K Buy
+1,000
New +$203K 0.02% 178

Other funds holding TDOC

Albion Financial Group's TDOC Position: Q2 2023 in Review

Albion Financial Group sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 1,000 shares — an estimated $25.9K sold.

Albion Financial Group first reported a position in TDOC in Q4 2020 and held it in 9 quarters. The position peaked at $200K in Q4 2020. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Albion Financial Group reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Albion Financial Group sold 1,000 Teladoc Health shares in Q2 2023, an estimated $25.9K.
  • Albion Financial Group first reported a position in Teladoc Health in Q4 2020 and held it in 9 quarters.
  • Albion Financial Group's Teladoc Health position peaked at $200K in Q4 2020.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Albion Financial Group's 13F filing for Q2 2023, filed 25 Jul 2023.